Top Markets
#1 GEKKO GEKKO +43.17%
#2 TENDIES TENDIES +39.20%
#3 ADO Protocol ADO Protocol +38.64%
#4 Pons Pons +36.87%
#5 Helium Helium +27.97%
#6 Prom Prom +25.93%
#7 龙虾 (Lobster) 龙虾 (Lobster) +20.86%
#8 Nillion Nillion +18.38%
#9 o1.exchange o1.exchange +17.72%
#10 Main Street Yield Main Street Yield +17.48%
Coin of the day
GEKKO GEKKO
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Gubra A/S Gubra A/S

Gubra A/S

GUBRA
Rangering i aksjer #9438
Gubra A/S is a biotechnology firm engaged in two core activities: offering... Gubra A/S is a biotechnology firm engaged in two core activities: offering contract research organization (CRO) services for pre-clinical development, and advancing its own internal early-stage drug and target discovery initiatives. Its CRO division provides specialized pre-clinical research and development support to companies in the pharmaceutical and biotechnology sectors. These services encompass a wide range of capabilities, including in vivo pharmacology, tissue analysis, various assay development, molecular pharmacology, bioanalytical testing, next-generation sequencing (NGS), and both two-dimensional and three-dimensional imaging techniques. Established in 2008, the company has its headquarters in Horsholm, Denmark.
Aksjekurs
$61.73
Sist synkronisert: 2026-08-28
Markedsverdi
$1.01B
Endring (1 dag)
-1.02%
Endring (1 år)
5.10%
Land
DK
Handel Gubra A/S (GUBRA)

Kategori

Healthcare
Aksjeprishistorikk for Gubra A/S (GUBRA)
Høyeste sluttskurs: $60.73 den 2026-08-01

Laveste sluttskurs: $16.05 den 2023-04-01
Aksjeprishistorikk for Gubra A/S fra 2023 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -19.73%
2025 -18.20%
2024 437.82%
2023 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH